Metastases and Recurrence Risk Factors in Endometrial Cancer-The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures

被引:1
|
作者
Markowska, Anna [1 ]
Baranowski, Wlodzimierz [2 ]
Pitynski, Kazimierz [3 ]
Chudecka-Glaz, Anita [4 ]
Markowska, Janina [5 ]
Sawicki, Wlodzimierz [6 ]
Srivastava, Sanjay K.
机构
[1] Poznan Univ Med Sci, Dept Perinatol & Womens Dis, PL-60535 Poznan, Poland
[2] Mil Inst Med, Dept Gynecol Oncol, PL-04141 Warsaw, Poland
[3] Jagiellonian Univ Med Coll, Dept Gynecol & Oncol, PL-31501 Krakow, Poland
[4] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adolesc, PL-70204 Szczecin, Poland
[5] Gynecol Oncol Ctr Poznan, Poznanska 58A, PL-60850 Poznan, Poland
[6] Med Univ Warsaw, Dept Obstet Gynecol & Gynecol Oncol, Warsaw, Poland
关键词
endometrial cancer metastasis; TCGA classification; hormones; ultrasonography; hysteroscopy; LYMPH-NODE METASTASIS; PREOPERATIVE PREDICTION; MYOMETRIAL INVASION; HYSTEROSCOPY; CARCINOMA; ULTRASOUND; GRADE; CELLS; DISSEMINATION; MODEL;
D O I
10.3390/cancers16010179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This paper delves into the issue of metastatic endometrial cancer (EC), which significantly impacts treatment success and overall survival rates. The study explores various factors contributing to metastasis, including the molecular profile of EC, hormone activity (like estrogen and prolactin), and pro-inflammatory adipocytokines. It also investigates how altered microRNA expression affects gene regulation linked to the dissemination of the cancer. The paper highlights the importance of imaging techniques, particularly transvaginal ultrasound with tumor-free distance (uTFD), in detecting metastases. Additionally, it discusses how diagnostic and therapeutic methods can influence the spread of EC, with hysteroscopy potentially increasing risk in advanced stages and laparoscopic hysterectomy being safer if performed with care. This research could improve our understanding of EC and guide better diagnostic and treatment strategies.Abstract The presence of metastatic endometrial cancer (EC) is a key problem in treatment failure associated with reduced overall survival rates. The most common metastatic location is the pelvic lymph nodes, and the least common is the brain. The presence of metastasis depends on many factors, including the molecular profile of cancer (according to the TCGA-Genome Atlas), the activity of certain hormones (estrogen, prolactin), and pro-inflammatory adipocytokines. Additionally, an altered expression of microRNAs affecting the regulation of numerous genes is also related to the spread of cancer. This paper also discusses the value of imaging methods in detecting metastases; the primary role is attributed to the standard transvaginal USG with the tumor-free distance (uTFD) option. The influence of diagnostic and therapeutic methods on EC spread is also described. Hysteroscopy, according to the analysis discussed above, may increase the risk of metastases through a fluid medium, mainly performed in advanced stages of EC. According to another analysis, laparoscopic hysterectomy performed with particular attention to avoiding risky procedures (trocar flushing, tissue traumatization, preserving a margin of normal tissue) was not found to increase the risk of EC dissemination.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] HORMONAL FACTORS AND ENDOMETRIAL CANCER RISK BY PARITY
    Schonfeld, S. J.
    Hartge, P.
    Pfeiffer, R. M.
    Freedman, D. M.
    Greenlee, R. T.
    Linet, M. S.
    Park, Y.
    Schairer, C.
    Schatzkin, A.
    Visvanathan, K.
    Lacey, J. V.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S22 - S22
  • [2] THE ROLE OF PROGNOSTIC RISK FACTORS IN ENDOMETRIAL CANCER RECURRENCE: A RETROSPECTIVE STUDY
    Spagnol, G.
    Pezzani, I.
    Corrao, G.
    Gava, S.
    Bernardini, V.
    Kilzie, S.
    Artioli, G.
    Bonaldo, G.
    Noventa, M.
    Carlo, S.
    Busato, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A82 - A83
  • [3] The role of nesfatin and selected molecular factors in various types of endometrial cancer
    Markowska, Anna
    Szarszewska, Monika
    Knapp, Pawel
    Grybos, Anna
    Grybos, Marian
    Marszalek, Andrzej
    Filas, Violetta
    Wojcik-Krowiranda, Katarzyna
    Swornik, Malgorzata
    Markowska, Janina
    GINEKOLOGIA POLSKA, 2019, 90 (10) : 571 - 576
  • [4] Risk Factors for Node Affectation and Recurrence in Endometrial Cancer
    Alonso, Sonsoles
    Lapuente, Fernando
    Gonzalez-Martin, Antonio
    Chiva, Luis
    CURRENT WOMENS HEALTH REVIEWS, 2011, 7 (04) : 320 - 325
  • [5] Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome
    Dashti, Seyedeh Ghazaleh
    Chau, Rowena
    Ouakrim, Driss Ait
    Buchanan, Daniel D.
    Clendenning, Mark
    Young, Joanne P.
    Winship, Ingrid M.
    Arnold, Julie
    Ahnen, Dennis J.
    Haile, Robert W.
    Casey, Graham
    Gallinger, Steven
    Thibodeau, Stephen N.
    Lindor, Noralane M.
    Le Marchand, Loic
    Newcomb, Polly A.
    Potter, John D.
    Baron, John A.
    Hopper, John L.
    Jenkins, Mark A.
    Win, Aung Ko
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 61 - 71
  • [6] An aggregated analysis of hormonal factors and endometrial cancer risk by parity
    Schonfeld, Sara J.
    Hartge, Patricia
    Pfeiffer, Ruth M.
    Freedman, D. Michal
    Greenlee, Robert T.
    Linet, Martha S.
    Park, Yikyung
    Schairer, Catherine
    Visvanathan, Kala
    Lacey, James V., Jr.
    CANCER, 2013, 119 (07) : 1393 - 1401
  • [7] Do uterine risk factors or lymph node metastases drive overall recurrence risk in patients with endometrial cancer?
    Bishop, E.
    Nugent, E.
    Mathews, C.
    Moxley, K.
    Tenney, M.
    Mannel, R.
    Walker, J.
    Landrum, L.
    Moore, K.
    McMeekin, D.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S33 - S33
  • [8] Role of reproductive factors on the risk of endometrial cancer
    Parazzini, F
    Negri, E
    La Vecchia, C
    Benzi, G
    Chiaffarino, F
    Polatti, A
    Franceschi, S
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (06) : 784 - 786
  • [9] RISK FACTORS FOR RECURRENCE IN WOMEN WITH LOW-RISK ENDOMETRIAL CANCER
    Choi, Y. J.
    Suh, D. H.
    Kim, T. H.
    Kim, N. K.
    Kim, K.
    No, J. H.
    Kim, Y. B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1061 - 1061
  • [10] SEARCH FOR RISK FACTORS FOR RECURRENCE IN INTIALLY LOW RISK ENDOMETRIAL CANCER: SOMATIC MUTATIONS AND HISTOPATHOLOGICAL CHANGES
    Imboden, S.
    Taghavi, K.
    Rau, T.
    Papadia, A.
    Mohr, S.
    Siegenthaler, F.
    Simillon, C.
    McKinnon, B.
    Mueller, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1104 - 1104